IntelGenx Technologies
Overview
Raised: $196,080
Rolling Commitments ($USD)
Active
04/28/2024
26,144%
1%
$2,686
117
1999
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Low
High
Balance Sheet
Cash and Cash Equivalents |
$1,904,000 |
Investment Securities |
$173,000 |
Accounts and Notes Receivable |
$606,000 |
Property, Plant and Equipment (PP&E) |
$3,976,000 |
Property and Equipment |
$3,976,000 |
Total Assets |
$8,113,000 |
Accounts Payable & Accrued Liabilities |
$3,193,000 |
Long Term Debt |
$8,500,000 |
Total Liabilities |
$19,019,000 |
Total Stockholders' Equity |
$-10,906,000 |
Total Liabilities and Equity |
$8,113,000 |
Statement of Comprehensive Income Information
Total Revenues |
$318,000 |
Costs & Expenses Applicable to Rev |
$2,688,000 |
Depreciation and Amortization |
$200,000 |
Net Income |
$-2,759,000 |
Earnings Per Share - Basic |
$-0.01 |
Earnings Per Share - Diluted |
$-0.01 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual